CurrentRheuma
Get Weekly

Topic · page 28 of 47

Lupus & antiphospholipid syndrome

Systemic and cutaneous lupus erythematosus, lupus nephritis, neuropsychiatric lupus, disease activity, remission and low disease activity, damage, antimalarials and targeted treatment; antiphospholipid antibodies and antiphospholipid syndrome, thrombotic and obstetric

Briefs 1,081–1,120 of 1,848 placed here, newest publication first

Briefs in Lupus & antiphospholipid syndrome

Newest publication first

  1. Arthritis Care Res (Hoboken)

    Effect of Shared Decision‐Making on Trust in Physicians in the Management of Systemic Lupus Erythematosus: The Trust Measurement for Physicians and Patients With Systemic Lupus Erythematosus Prospective Cohort Study

    Cohort study

  2. Rheumatology (Oxford)

    Placental lesions in systemic lupus erythematosus pregnancies associated with small for gestational age infants

    Cohort study

  3. Ann Rheum Dis

    Disentangling the riddle of systemic lupus erythematosus with antiphospholipid syndrome: blood transcriptome analysis reveals a less-pronounced IFN-signature and distinct molecular profiles in venous versus arterial events

    Mechanistic study

  4. Lancet Rheumatol

    Attainment of remission and low disease activity after treatment with belimumab in patients with systemic lupus erythematosus: a post-hoc analysis of pooled data from five randomised clinical trials

    Meta-analysis

  5. Lupus Sci Med

    Alignment of contraception use with the ACR reproductive health guidelines in women with systemic lupus erythematosus within the RISE registry

    Cohort study

  6. Scand J Rheumatol

    Macrophage colony-stimulating factor receptor/CD115 + non-classical monocytes are expanded in systemic lupus erythematosus and associated with lupus nephritis

    Cross-sectional study

  7. Lupus

    Clinical significance of serum soluble scavenger receptor CD163 in patients with lupus nephritis

    Diagnostic or prognostic study

  8. Lupus

    Beyond paraneoplastic neurological syndromes: Anti-neuronal antibodies in neuropsychiatric systemic lupus erythematosus

    Cross-sectional study

  9. Lupus

    Evaluation of survivin expression and regulating miRNAs of survivin expression in peripheral blood mononuclear cells in systemic lupus erythematous patients

    Case-control study

  10. Arthritis Care Res (Hoboken)

    Misdiagnosis, Missed Diagnosis, and Delayed Diagnosis of Lupus: A Qualitative Study of Rheumatologists

    Research article

  11. RMD Open

    Sensitivity of classification criteria from time of diagnosis in an incident systemic lupus erythematosus cohort: a population-based study from Norway

    Cohort study

  12. Lupus

    Study of electrocardiographic corrected QT interval and QT dispersion abnormalities, erythrocyte sedimentation rate, serum uric acid in patients with systemic lupus erythematosus

    Case-control study

  13. Lupus Sci Med

    Circulating extracellular vesicles in Systemic Lupus Erythematosus: physicochemical properties and phenotype

    Cross-sectional study

  14. Lupus Sci Med

    Effects of systemic lupus erythematosus on the brain: a systematic review of structural MRI findings and their relationships with cognitive dysfunction

    Meta-analysis

  15. Lupus

    Gut microbiome composition and intestinal immunity in antiphospholipid syndrome patients versus healthy controls

    Cross-sectional study

  16. Lupus

    Utility of pan-immune-inflammation value as a predictor of the prognosis of childhood lupus

    Cohort study

  17. Lupus

    Treatment patterns in patients with systemic lupus erythematosus in New Zealand

    Cross-sectional study

  18. Lupus

    Blood-based biomarkers of neuronal and glial injury in active major neuropsychiatric systemic lupus erythematosus

    Case-control study

  19. Lancet Rheumatol

    Pregnancy outcome predictors in systemic lupus erythematosus: a systematic review and meta-analysis

    Meta-analysis

  20. Rheumatology (Oxford)

    The implication of anti-Ro60 with or without anti-Ro52 antibody in patients with systemic lupus erythematosus

    Cohort study

  21. Lupus

    Retrospective cohort study identifying pulmonary complications in a cohort of patients with systemic lupus erythematosus

    Cohort study

  22. Lupus

    Anti-SARS-CoV-2 mRNA vaccination among patients living with SLE in Sweden: Coverage and clinical effectiveness

    Cohort study

  23. Rheumatology (Oxford)

    Short- and long-term outcomes of patients with pure membranous lupus nephritis compared with patients with proliferative disease

    Cohort study

  24. Arthritis Rheumatol

    A Genome‐Wide Association Study Suggests New Susceptibility Loci for Primary Antiphospholipid Syndrome

    Meta-analysis

  25. Lupus

    Seroprevalence of Toxoplasma gondii immunoglobulins and its association with systemic lupus erythematosus: A systematic review and meta-analysis

    Meta-analysis

  26. Semin Arthritis Rheum

    Interplay between polygenic risk score and solar insolation: Implication for systemic lupus erythematosus diagnosis and pathogenesis

    Case-control study

  27. Lupus

    Investigating physical inactivity and associated health parameters in patients with systemic lupus erythematosus

    Cross-sectional study

  28. Arthritis Rheumatol

    Association of Autoantibody Concentrations and Trajectories With Lupus Nephritis Histologic Features and Treatment Response

    Cohort study

  29. Arthritis Care Res (Hoboken)

    Hydroxychloroquine and Pre‐eclampsia in a Diverse Cohort of Women With Systemic Lupus Erythematosus

    Cohort study

  30. Lupus

    LncRNA XIST/miR-381-3P/STAT1 axis as a potential biomarker for lupus nephritis

    Diagnostic or prognostic study

  31. Lupus

    Tofacitinib versus thalidomide for mucocutaneous lesions of systemic lupus erythematosus: A real-world CSTAR cohort study XXVII

    Cohort study

  32. Arthritis Rheumatol

    Efficacy and Safety of Upadacitinib or Elsubrutinib Alone or in Combination for Patients With Systemic Lupus Erythematosus: A Phase 2 Randomized Controlled Trial

    Randomized controlled trial

  33. Rheumatology (Oxford)

    Kidney whole-transcriptome profiling in primary antiphospholipid syndrome reveals complement, interferons and NETs-related gene expression

    Mechanistic study

  34. Lupus

    Anifrolumab for systemic lupus erythematosus with multi-refractory skin disease: A case series of 18 patients

    Cohort study

  35. Arthritis Rheumatol

    Performance of the 2023 American College of Rheumatology/EULAR Classification Criteria for Antiphospholipid Syndrome in a Mexican Cohort

    Diagnostic or prognostic study

  36. Lupus Sci Med

    Damage in a large systemic lupus erythematosus cohort from the Spanish Society of Rheumatology Lupus Registry (RELESSER) with emphasis on the cardiovascular system: a longitudinal analysis

    Cohort study

  37. Rheumatology (Oxford)

    Severe haematological involvement in children with systemic lupus erythematosus and clinical associations

    Cohort study

  38. Lupus

    Comparison of clinical and serological features in thrombotic antiphospholipid syndrome patients, with and without associated systemic lupus erythematosus, followed for up to 42 years: A single centre retrospective study

    Cohort study

  39. J Rheumatol

    Vitamin K Antagonists for Pregnant Women With Antiphospholipid Antibodies: A Scoping Review

    Research article

  40. JAMA Netw Open

    Hydroxychloroquine and Cardiovascular Events in Patients With Systemic Lupus Erythematosus

    Case-control study

All 1,848 Briefs in ExploreShowing Briefs 1,081–1,120 of 1,848, newest first